Today, Gleamer, the leading European manufacturer in AI-powered solutions for medical imaging, announced a Series B financing of €27 million. This operation is led by Supernova Invest, co-led by Heal Capital and backing from Gleamer’s long-term partners XAnge, Elaia, Bpi France, MACSF, UI Investissement, and Crista Galli Ventures, as well as several European radiologists. This new investment will enable Gleamer to expand its portfolio of solutions, strengthen its European and American teams, and accelerate its international development plans. Total funds raised to date amount to €35.5 million (which includes a Series A funding round of €7.5 million in 2020 and seed funding of €1.5 million in 2018).